Cy5.5 NHS ester (non-sulfonated)
Cyanine5.5 NHS ester is a reactive dye for the labeling of peptides, proteins, and oligonucleotides that contain amino-groups. Cy5.5-NHS ester is a near-infrared fluorescence dye able to dissolve in DMF and DMSO with the excitation maximum and emission maximum around 675 nm and 693 nm respectively [1]. The reagent is not only used for labeling moleculars contain amino groups but also used for labeling plasmid DNA [2].For biomolecule labeling, the labeling reagent has low aqueous solubility, using of organic co-solvent to dissolve this molecular is necessary for efficient reaction. First, Cyanine dye should be dissolved in organic solvent and then added to a solution of biomolecule in appropriate aqueous buffer.
Through the optical imaging of subcutaneous tumor xenografted mice, the subcutaneous U87MG tumor could be clearly distinguished from the surrounding background tissue from 30 min up to 24 h postinjection of 0.5 nmol Cy5.5-NHS. The tumor uptake of Cy5.5-NHS reached a maximum 30 minutes postinjection and slowly washed out over time [3].
References:
[1]. Ju Hee Ryu, Jin Hee Na, Ho Kyung Ko, et al. Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models. Biomaterials, 2014, 35: 2302-2311.
[2]. Laura-Lee Farrell, Joel Pepin, Cezary Kucharski, et al. A comparison of the effectiveness of cationic polymers poly-L-lysine (PLL) and polyethylenimine (PEI) for non-viral delivery of plasmid DNA to bone marrow stromal cells (BMSC). European Journal of Pharmaceutics and Biopharmaceutics, 2007, 65: 388–397.
[3]. Zhen Cheng, Jelena Levi, Zhengming Xiong, et al. Near-Infrared Fluorescent Deoxyglucose Analog for Tumor Optical Imaging in Cell Culture and in Living Mice. Bioconjug Chem., 2006, 17(3):662-669.
- 1. Weiqi Zhang, Yinghua Zeng, et al. "An in-situ peptide-antibody self-assembly to block CD47 and CD24 signaling enhances macrophage-mediated phagocytosis and anti-tumor immune responses." Nat Commun. 2024 Jul 6;15(1):5670. PMID: 38971872
- 2. Wentao Jiang, Huizi Xu, et al. "Artificial Neutrophils Against Vascular Graft Infection." Adv Sci (Weinh). 2024 Jun 14:e2402768. PMID: 38874399
- 3. Ziliang Dong, Lei Zhang, et al. "Procoagulant CaCO3-embedded embolic microspheres can potentiate transcatheter arterial embolization of hepatocellular carcinoma." Nano Today. Volume 55, April 2024, 102216.
- 4. Xuemei Lu, et al. "Engineered exosomes loaded with M1–8 peptide for targeted therapy of hepatocellular carcinoma." APPLIED materialstoday. Volume 37, April 2024, 102071.
- 5. Zhengchao Zhang, Dejun Ding, et al. "Supramolecular Nanozyme System Based on Polydopamine and Polyoxometalate for Photothermal-Enhanced Multienzyme Cascade Catalytic Tumor Therapy." ACS Appl Mater Interfaces. 2023 Aug 16;15(32):38214-38229. PMID: 37535452
- 6. Dan Yang, Jing Ning, et al. "Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel." Int J Nanomedicine. 2023 Jul 20;18:3989-4005. PMID: 37496690
- 7. Debin Zheng, Jingfei Liu, et al. "Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death." Acta Pharm Sin B. 2022 Jun;12(6):2740-2750. PMID: 35755291
- 8. Shaodan Ma, Shunan Gu, et al. "Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels." Mater Today Bio. 2022 May 19;15:100296. PMID: 35665233
- 9. Qi Wang , Ting Li, et al. "Engineered Exosomes with Independent Module/Cascading Function for Therapy of Parkinson's Disease by Multistep Targeting and Multistage Intervention Method." Adv Mater. 2022 Apr 18;e2201406. PMID: 35435282
- 10. Zi-Yan Wu, Jian-Min Shen, et al. "pH/Enzyme dual sensitive and nucleus-targeting dendrimer nanoparticles to enhance the antitumour activity of doxorubicin." Pharm Dev Technol. 2022 May 21;1-15 PMID: 35350969
- 11. Yuanyuan Li, Yangye Jin, et al. "Cyclo (RGD) peptide-decorated silver nanoparticles with anti-platelet potential for active platelet-rich thrombus targeting." Nanomedicine. 2022 Jan 14;41:102520. PMID: 35038589
- 12. Ziyu Wu, Rui Wu, et al. "Multi‐Pathway Microenvironment Regulation for Atherosclerosis Therapy Based on Beta‐Cyclodextrin/L‐Arginine/Au Nanomotors with Dual‐Mode Propulsion." Small. 2021 Dec 16;e2104120. PMID: 34918450
- 13. Xiaoyun Li, Rui Wu, et al. "Near-Infrared Light-Driven Multifunctional Tubular Micromotors for Treatment of Atherosclerosis." ACS Appl Mater Interfaces. 2021 Jul 7;13(26):30930-30940. PMID: 34156244
- 14. Zhanpeng Wen, Jie Zhan, et al. "Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction." Theranostics. 2021 Jan 27;11(8):3725-3741. PMID: 33664858
- 15. Qingle Ma, Qin Fan, et al. "Platelet-derived extracellular vesicles to target plaque inflammation for effective anti-atherosclerotic therapy." J Control Release. 2020 Dec 4;329:445-453. PMID: 33285103
- 16. Keman Cheng, Tao Du, et al. "Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma." ACS Appl Mater Interfaces. 2020 Nov 18. PMID: 33205941
- 17. Qinjun Chen, Yongqing He, et al. "Penetrable Nanoplatform for "Cold" Tumor Immune Microenvironment Reeducation." Adv Sci (Weinh). 2020 Jul 29;7(17):2000411. PMID: 32995118
- 18. Sheridan J.S. Carrington. "Differential Glycosylation of the Inwardly Rectifying Potassium Channel Kir7.1 by G protein-coupled Receptors." Vanderbilt University. 2019.
- 19. Qian Xu, Zheng Zhang, et al. "Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies." J Control Release. 2020 Oct 10;326:455-467. PMID: 32711027
- 20. Wang L, Yang C, et al. "Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma." Theranostics. 2020;10(15):6674-6694. PMID: 32550897
- 21. Xiaolei Zhang, Chuangnian Zhang, et al. "Dual pH-responsive "charge-reversal like" gold nanoparticles to enhance tumor retention for chemo-radiotherapy." Nano Research. 27 September 2019.
- 22. Jiang C, Qi Z, et al. "Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression." J Control Release. 2019 Jul 8. pii: S0168-3659(19)30394-3. PMID: 31295543
- 23. Jianmin Shen, Jing Chen, et al. "Enhanced lysosome escape mediated by 1, 2-dicarboxylic-cyclohexene anhydride-modified poly-L-lysine dendrimer as a gene delivery system." Journal Pre-proof. 10 December 2019. pii: S1818-0876(19)30883-9
- 24. Zou S, Duan B, et al. "Inhibition of tumor growth by β-glucans through promoting CD4(+) T cell immunomodulation and neutrophil-killing in mice." Carbohydr Polym. 2019 Jun 1;213:370-381. PMID: 30879681
- 25. Cheng M, Zhang Y, et al. "One-pot synthesis of acid-induced in situ aggregating theranostic gold nanoparticles with enhanced retention in tumor cells." Biomater Sci. 2019 Mar 6. PMID: 30839987
- 26. Jiang C, Qi Z, et al. "ATP-responsive low-molecular-weight polyethylenimine-based supramolecular assembly via host-guest interaction for gene delivery." Biomacromolecules. 2018 Dec 5. PMID: 30516950
- 27. Lu J, Zhao Y, et al."Biofunctional polymer-lipid hybrid high density lipoprotein-mimicking nanoparticles loading anti-miR155 for combined antiatherogenic effects on macrophages." Biomacromolecules. 2017 Aug 3. PMID: 28738148
Physical Appearance | A solid |
Storage | 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. The product is not stable in solution, please dissolve it immediately before use. |
M.Wt | 716.31 |
Cas No. | 1469277-96-0 |
Formula | C44H46ClN3O4 |
Solubility | ≥35.82 mg/mL in DMSO |
Chemical Name | 3-(6-((2,5-dioxopyrrolidin-1-yl)oxy)-6-oxohexyl)-1,1-dimethyl-2-((1E,3E,5E)-5-(1,1,3-trimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene)penta-1,3-dien-1-yl)-1H-benzo[e]indol-3-ium chloride |
SDF | Download SDF |
Canonical SMILES | CC1(C)C(/C=C/C=C/C=C2C(C)(C)C(C3=CC=CC=C3C=C4)=C4N\2C)=[N+](CCCCCC(ON5C(CCC5=O)=O)=O)C6=C1C7=CC=CC=C7C=C6.[Cl-] |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Excitation max (nm) | 684 | Emission max (nm) | 710 |
Extinction Coefficient (M-1cm-1) | 209000 | Quantum Yield | 0.2 |
CF260 | 0.07 | CF280 | 0.03 |
Quality Control & MSDS
- View current batch:
Chemical structure

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data

Related Biological Data
